AP
About
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
Tags
Score Breakdown
44Traction
39Team
30Visibility
0Profile
50Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Ayala Pharmaceuticals do?
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
How much funding has Ayala Pharmaceuticals raised?
Ayala Pharmaceuticals has raised a total of $72M in funding. The most recent round on record is Series C.
When was Ayala Pharmaceuticals founded?
Ayala Pharmaceuticals was founded in 2017.
What industry does Ayala Pharmaceuticals operate in?
Ayala Pharmaceuticals operates in Life Sciences, Oncology, Therapeutics.
What is Ayala Pharmaceuticals's current status?
Ayala Pharmaceuticals's current operating status is: Merged.